Maturation of human immunodeficiency virus type 1 (HIV-1) is achieved by the proteolytic processing of Gag and Gag-Pol sites at at least 10 nonhomologous substrate sites by a viral protease (4, 14, 36) . This processing leads to the release of viral enzymes and structural proteins. In the absence of this proteolysis, immature noninfectious virions are produced (7) . For this reason, HIV-1 protease is a prime target for antiviral therapy (48, 54) .
The three-dimensional structure of this 22-kDa dimeric protease comprises a terminal region, an active site, and a core domain (29, 53) . The active site residues are located at the dimer interface, with one catalytic aspartate (Asp25/25Ј) donated by each monomer (53, 54) . The substrates bind the active site in an extended conformation forming mainly backbone hydrogen bonds (39, 51) . On the opposite side of Asp25, two ␤-hairpins, known as the flaps, one from each monomer, wrap around the substrates. In addition to its interactions with the substrates, the flap tips (Ile50-Gly51) also participate in intermolecular interactions. As a common feature of aspartyl proteases for ligand binding to occur, several structural rearrangements must take place (13, 15, 24, 28, 45) . The flaps open to allow substrate binding, and upon substrate recognition, they must close to attain the canonical "closed" conformation of HIV-1 protease. Whether the flap movements are synchronized between the monomers, as HIV-1 protease is homodimeric, or whether they move in an asynchronous fashion, as found in molecular dynamics simulations (22, 37, 45) , is still to be verified structurally. The opening and the closing of the flaps are not likely random events but involve a few or several discrete structural intermediates. Nuclear magnetic resonance (NMR) experiments proposed that an ensemble of flap conformations are possible between open and closed stages of the flaps (12, 16) . Whether other regions of the protease also move in concert with the flaps is not known. However, trapping any of these intermediates in a crystal is a challenge.
Our crystallographic investigations of wild-type (WT) and drug-resistant variants of HIV-1 protease complexed with several of its substrates have revealed a conserved shape we defined as the "substrate envelope," which we hypothesize is crucial for substrate specificity (39) (40) (41) (42) . Further studies provided structural insights into why a prime drug-resistant mutation, V82A (5, 8, 10, 31, 46) , has less effect on substrate binding than on inhibitor binding as Val82 interacts more closely with the drugs than with natural substrates (41) . The nucleocapsid-p1 (NC-p1) substrate, however, coevolves (AlaP2Val) in a correlated manner with the V82A mutation (3, 6, 9, 23, 56) . Processing of the NC-p1 substrate is the slowest and rate-determining cleavage step in the maturation of Gag (38, 50, 55) . Unlike in other substrate-V82A protease complexes, PheP1Ј forms hydrophobic interactions with Val82, which are lost in the V82A complex (40) . The AlaP2 in WT NC-p1 does not fill the S2 pocket, which is then compensated for by the ValP2 in the AP2V mutant (40) . Thus, the AP2V coevolution in NC-p1 is structurally correlated by an interdependency between the P1Ј and P2 substrate sites.
Here we report two new crystal structures of inactive D25N variants of HIV-1 protease bound to two variants of peptides corresponding to the NC-p1 cleavage site. Unlike the complexes of NC-p1 which were used to explain the coevolution of this substrate (40) , these new structures exhibit a novel flap conformation: One of the flaps remains in the canonical "flapclosed" geometry, while the other flap exhibits an unusual intermediate conformation. This is the first instance in which an asymmetric conformation of the flap is observed in HIV-1 protease. Detailed structural analyses provide a plausible structural model for how drug-resistant mutants continue to recognize substrates.
MATERIALS AND METHODS
Peptide acquisition. Two decameric peptides representing the P4-to-P6Ј (P4-P6) region of the WT and AP2V variants of NC-p1 were purchased from 21st Century Biochemicals, Marlboro, Mass. (see Table 1 for sequence).
Nomenclature. To avoid confusion, the various crystal structures discussed here will use the following nomenclature:
(substrate variant) substrate (protease variant) . For instance, WT D25N protease bound to WT NC-p1 with flaps in canonical and flap-intermediate conformations will be denoted by WT NCp1 WT and WT NCp1 WT-Int , respectively.
Protein purification and crystallization. Mutagenesis, protein purification, and crystallization screens were carried out exactly as performed earlier (40) .
Data collection. Data for WT NCp1 WT-Int were collected at the in-house Raxis IV image plate mounted on a Rigaku X-ray generator, and data for AP2V NCp1 V82A-Int were obtained from a synchrotron beam line at Advanced Light Source (ALS), Lawrence-Berkeley Laboratory, Berkeley, Calif. The WT and AP2V complexes diffracted to respective resolutions of 1.85 and 1.44 Å. Raw data were indexed using Denzo and scaled using ScalePack (30, 35) , and the complete data collection statistics are listed in Table 1 .
Structure solution and crystallographic refinement. The programs within the CCP4i interface (4a) were used throughout the crystallographic operations. The molecular replacement program AMoRe (34) was used to solve the structures using those reflections within the resolution range 12 to 3.5 Å. A WT HIV-1 protease complexed with the inhibitor TMC114 (Protein Data Bank [PDB] code 1T3R) (19) was used as the starting model. The phases were improved by building solvent molecules using ARP/wARP (32) , and interactive model building was carried out using the graphics program O (17) . Clear electron density for a different conformation was observed for the flap which interacts with the P1Ј-P6Ј side of the substrate (Ile47Ј-Ile54Ј). Conjugate gradient refinement using Refmac5 (33) was performed by incorporating Schomaker and Trueblood tensor formulation of TLS (translation, libration, and screw rotation) parameters (21, 44b, 49) . The interactive model building and crystallographic refinement were carried out iteratively until R and R free converged. The final refinement statistics are presented in Table 1 . The crystal coordinates have been deposited in the Protein Data Bank, and their accession codes are also listed in Table 1 .
Structure analysis. (i) Structural superimpositions. All of the complexes used in this analysis were superimposed on the WT D25N complex of capsid-p2 peptide (PDB code 1F7A) (39) . CA-p2 WT was chosen in order to preserve consistency with all of our previous analyses. The terminal region (Pro1-Pro9 and Arg87-Phe99) from both monomers was used in this operation, and the superimposition was carried out such that the peptide orientation was preserved.
(ii)Double-difference plots. Distances between all the C ␣ atoms within each dimer were computed ( n D ij , where D is the double difference and i and j are residue numbers). This was repeated for each of the "n" structures. Double differences (D) were generated as a (i ϫ j) matrix by computing the difference of the differences between the two dimers (D ϭ n D ij Ϫ nЈ D ij ). The (i ϫ j) matrix was then displayed as a contour diagram using GnuPlot (52) .
RESULTS
Overall structure of protease. Crystal structures of WT and V82A variants of an inactive D25N HIV-1 protease enzyme were determined by cocrystallizing them with WT and AP2V variants of NC-p1 substrate peptide, respectively. The corresponding resolutions are 1.85 and 1.44 Å. The three-dimen- sional arrangements of the terminal region forming the dimer interface, the active site region, and the core region, which is an extension of the active site, are all preserved as in other HIV-1 protease structures. The flap of the monomer which interacts with the P1Ј-P6Ј side of the substrate (monomer B) exhibits a different geometry with the tip of the flap displaced by 4 Å. The flap of the monomer which interacts with the N-terminal side of the substrate (monomer A), on the other hand, adopts the usual flap geometry (Fig. 1 ). Other structures with semiopen flap conformation are symmetric (25, 44, 47) ; therefore, the two NC-p1 flap-intermediate structures represent a novel flap arrangement. The method used to obtain the crystals of these flap-intermediate complexes is almost identical to the one followed in determining the corresponding flap-closed structures (40) ; in fact, the crystals were formed in the same crystallization tray. This conformation must represent an energetically stable form of the enzyme that can nucleate crystals similarly to the closed conformation. The exact reasons for this are unknown. Perhaps because NC-p1 is a poorer substrate (38, 50, 55) , the binding of it is less strong, thus allowing for the possibility of more flap conformations to be accessed.
The root mean square deviations (RMSDs) for structural superposition were computed for all of the C ␣ atoms. The RMSD between WT NCp1 WT-Int and AP2V NCp1 V82A-Int is 0.22 Å, and the RMSD for WT NCp1 WT and AP2V NCp1 V82A is 0.53 Å. Thus, the structural agreement between the flap-intermediate complexes is better than it is between the flap-closed structures. The structural differences between the two flapintermediate complexes were visualized by generating double-difference plots (Fig. 2a) . Absence of significant peaks in the plot indicates that the structures of the two flap-intermediate complexes are similar. However, the WT NCp1 WT and AP2V NCp1 V82A complexes exhibit several relative shifts over 0.5Å (Fig. 2b) . A comparison between WT NCp1 WT-Int and WT NCp1 WT also revealed several differences (Fig. 2c) , with the flap of monomer B exhibiting the largest difference. The peaks (marked A1 and A2 in Fig. 2c ) indicate the structural changes by the P1 loop (Gly78-Asn83) which pack closer to each other in the WT NCp1 WT-Int structure than in the corresponding final structures. The distance between the C ␣ atoms of Pro81 and Pro81Ј is 1 Å shorter in WT NCp1 WT-Int than in WT NCp1 WT (Fig. 2e) , which is also the case in comparing AP2V NCp1 V82A-Int and AP2V NCp1 V82A (Fig. 2e) . The peaks (marked B1 and B2 in Fig.  2c ) indicate a shortening of distance between the closed flap (of monomer A) and the P1 loops in WT NCp1 WT-Int (peaks marked B1 and B2 in Fig. 2c) . Thus, the P1 loops are closest to AsnP1 and PheP1Ј prior to complete closure of the flaps. As the flaps engage the substrates, the P1 loops relax open and move to their final position. The movements of P1 loops may hence be anticorrelated such that they contact the P1 and P1Ј residues of the substrate and relax open as the flaps close down.
Crystal packing. Crystals for all four NC-p1 complexes grew in a P2 1 2 1 2 1 space group with similar unit cells (Table 1) and with one HIV-1 protease dimer in each asymmetric unit. The region around the flaps is not influenced by crystal packing in any of the complexes (Fig. 3) . In fact, the residues in symmetryrelated molecules, within 5Å of the flaps, do not change conformation between the complexes (Fig. 3c) . There is enough space within the crystal lattice for either of the flaps to open. However, only the flap of monomer B adopts a flap-interme- (Fig. 3d) . A comparison of the backbone (, ) angles with corresponding NC-p1 complexes exhibiting flap-closed arrangements reveals that the flap region of monomer B, en- . Panels were generated using GnuPlot (52) . (e) Structural superposition of the P1 loops and the flaps for the four NC-p1 complexes: The movements of P1 loops are inversely correlated with respect to the flap movements as illustrated by the arrows. The color coding is as follows: red, WT NCp1 WT ; green, WT NCp1 WT-Int ; orange, AP2V NCp1 V82A ; cyan, AP2V NCp1 V82A-Int . This panel and Fig. 3c, 4 , and 5c and d were generated using MidasPlus (11).
compassing Met46Ј-Ile54Ј, confers a sharp alteration in conformation (Ile47Ј, ⌬ ϳ12°and ⌬ ϳ20°; Gly48Ј, ⌬ ϳ60°and ⌬ ϳ140°; Phe53Ј, ⌬ ϳ25°and ⌬ ϳ180°; Ile54Ј, ⌬ ϳ40°a nd ⌬ ϳ20°) (Fig. 1a and c) . Thus, there is a structural asymmetry between the flaps within the dimer; however, the carbonyl oxygens of Ile50 point toward each other in both monomers ( 50 ϳ50°and 50 Ј ϳ50°) (Fig. 1c) . In the flapclosed structure, the carbonyl oxygens of Ile50 and Ile50Ј are Substrate-protease hydrogen bonds. The substrate-protease hydrogen bonds are shown in Table 2 . There are 11 substrateprotease hydrogen bonds in WT NCp1 WT-Int , and there are 13 and 15 substrate-protease hydrogen bonds for the two substrate peptide conformations in AP2V NCp1 V82A-Int . In both of the complexes, AsnP1 ND2 makes a hydrogen bond to Gly27 O (Fig. 5a ). This hydrogen bond, which is also found in AP2V NCp1 V82A (Fig. 5b) , is a unique interaction of the NC-p1 substrate in which the side chain of a P1 residue forms a direct hydrogen bond. The flap residue Gly48 forms backbone hydrogen bonds with the P4-P1 side of the substrate, while Gly48Ј does not form hydrogen bonds with the P1Ј-P6Ј side due to the flap movement (Fig. 5a ). Despite flap movement, however, the P1Ј-P6Ј side forms conserved hydrogen bonds with Gly27Ј O and Asp29Ј N. The substrate-protease hydrogen bonds in the flap-intermediate complexes were compared with those in the corresponding flap-closed complexes (Fig. 5b) . Ten hydrogen bonds are conserved between WT NCp1 WT and AP2V NCp1 V82A , which include the 4 formed by the flap residue Gly48/Gly48Ј (Table 2 ). Of these 10 conserved hydrogen bonds, 7 and 8 are NCp1 V82A-Int , respectively, with comparable hydrogen bonding distances. Barring hydrogen bonds by Gly48Ј, the alteration in flap geometry has less influence on substrate-protease hydrogen bonds.
Water-mediated substrate-protease bridges. The active site waters which are conserved among other HIV-1 protease-substrate complexes (2, 26, 46) are also present in the NC-p1 flap-intermediate complexes (labeled W1 to W5 in Fig. 5a and  b) . The water site W1, which coordinates Ile50/50Ј N and P2 O and P1Ј O in a tetrahedral geometry in most flap-closed structures, is also observed in the flap-intermediate structures, despite changes in the flap conformation. This water is stabilized by another water, W7, which mimics the position of Ile50Ј N in the flap-intermediate conformation and bridges W1 with the new Ile50Ј N, thereby preserving the geometry (Fig. 5a ). Two waters, W6 and W8, have unique geometries in all of the NC-p1 complexes. W6 bridges AsnP1 ND2 with Gly27 O, while W8 mediates GlyP3Ј O to Gly48Ј N in the flap-intermediate complexes and P4Ј O to Gly48Ј N in the flap-closed complexes. Thus, the water bridging network between the flap-intermediate and the flap-closed structures, for the most part, is also preserved.
van der Waals interactions. The side chain to side chain van der Waals (VDW) contacts between the substrate peptide and protease for all four NC-p1 complexes are summarized in Table 3 . In both WT complexes, AlaP2, the AP2V substrate mutation site, makes a lone VDW interaction. The valine mutation in the V82A-AP2V complexes enables ValP2 to form five and nine contacts, all hydrophobic, in AP2V NCp1 V82A-Int and AP2V NCp1 V82A , respectively. The major contributor to the loss of four VDW contacts in AP2V NCp1 V82A-Int is the alteration of the flap in monomer B, suggesting complete flap closure will stabilize the P2 residue. In the flap-intermediate complexes, the residues involved in VDW interactions with LeuP2Ј, Ala28Ј and Val32Ј, are conserved; however, upon flap closure, Ile50 and Ile47Ј also contact LeuP2Ј (Table 3 ). The structures of GlyP3Ј and its VDW contacts (with Arg8 and Asp29Ј) are highly conserved among the four NC-p1 complexes.
The numbers of VDW contacts made by AsnP1 are similar between the two flap-intermediate structures, while they are significantly different between the two flap-closed complexes (Table 3) . Presumably, the V82A mutation is responsible for most of the loss in VDW contacts in AP2V NCp1 V82A (total contacts, 7; 4 by the P1 loop) compared to WT NCp1 WT (total contacts, 11; 7 by the P1 loop). However, in AP2V NCp1 V82A-Int , the P1 loop shifts toward the center of the dimer packing against AsnP1 (total contacts, nine; six by the P1 loop), regaining some additional VDW interactions.
The most significant changes in VDW interactions are exhibited by PheP1Ј. In both WT complexes, Val82 forms five VDW interactions which are lost in AP2V NCp1 V82A due to the V82A mutation. In AP2V NCp1 V82A-Int , however, Ala82 CB participates in four VDW interactions (Table 3 and Fig. 5c ). As in AP2V NCp1 V82A-Int , the P1 loop forms more contacts with PheP1Ј in WT NCp1 WT-Int (10 contacts) than in WT NCp1 WT (8 contacts) . The participation of Ala82 in substrate-protease VDW interaction prior to complete flap closure suggests two interrelated scenarios. (i) Residue 82 forms VDW contacts with the substrate prior to flap closure regardless of amino acid type (Fig. 5c). (ii) Upon flap closure, residue 82, a member of the P1 loop, moves away from the active site (Fig. 5d) , thus altering substrate-protease VDW interactions.
DISCUSSION
The results of the two flap-intermediate NC-p1 complexes emphasize two aspects of substrate recognition by HIV-1 protease. (i) The flap interacting with the P4-P1 side of the substrate closes first, thereby reiterating our hypothesis that P3-P1 residues are crucial for substrate recognition. (ii) The P1 loops move toward the P1 and P1Ј residues of the substrates prior to flap closure, and upon flap closure the P1 loops relax open toward their final position. In addition, the flap-intermediate structures presented here are very similar in structure (Fig. 2a) , suggesting that these structures are not a random conformation but represent a highly conserved discrete structural inter- mediate. This is consistent with results obtained from NMR studies (12, 16) , and therefore a discrete structural intermediate in substrate recognition by HIV-1 protease has been trapped. Both of the flaps in the dimer could potentially assume an intermediate geometry within this crystal form; however, only the flap interacting with the P4-P1 side of the substrate adopts a closed conformation, implying that the P3-P1 region of the substrate may be crucial for specificity (1, 27, 42) . The crystal structure of HIV-1 protease product complex retains only the P5-P1 side (Ac-Ser-Leu-Asn-Phe/) of the substrate Ac-SerLeu-Asn-Phe*Phe-Leu-Glu-Lys (PDB code 1YTH) (43) . This product complex further supports our claim that the P3-P1 side of the substrate is bound more stably.
The analysis of VDW interactions elucidates the intricate involvement of P1 loop in substrate binding prior to and after flap closure in substrate recognition. While the flaps are in transition, the P1 loops act as guides by supplying the necessary packing interaction to the substrate, especially to P1 and P1Ј. Ala82 contacts PheP1Ј in the flap-intermediate conformation (Fig. 5c) , while in the flap-closed structures, it moves away, resulting in loss of VDW contacts (Fig. 5d) , which implies that during initial stages of substrate recognition, the P1 and P1Ј sites make more VDW contacts than when the flaps are engaged. The P2 and P2Ј residues, however, require complete flap closure for optimal binding. This is consistent with why coevolution should take place at the P2 site in the NC-p1 substrate in response to the V82A protease mutation.
The inward movement of the P1 loop when the flaps adopt an intermediate conformation could be general for all WT and V82A variants of HIV-1 protease. We have also observed this flap-intermediate conformation in the crystal structure of a multidrug-resistant HIV protease variant (L10I/G48V/I54V/ L63P/V82A) complexed with nelfinavir (NFV) (unpublished data). This NFV complex also crystallized in the same space group as the NC-p1 structures with similar unit cell dimensions. The conformation of the flaps and the P1 loops of this NFV complex is the same as that of the NC-p1 flap-intermediate structures. More importantly, the positioning of the inhibitor NFV tilts by ϳ15°about the molecular dyad compared to NFV in the wild-type complex, presumably in a nonoptimal conformation (18) . In contrast, the substrates in the flap-intermediate complexes form a stable geometry which is ready for cleavage even in the intermediate state (Fig. 4) .
In light of the data presented, we postulate a structural mechanism for substrate recognition that occurs regardless of the presence or absence of drug-resistant mutations. Prior to flap closure, the substrate is already bound in an extended form and the substrate-protease VDW interactions are preserved in both the WT and drug-resistant protease variants. When the flaps close, the mutation sites move to their final positions, thereby impacting the efficient binding of inhibitors but not the binding of substrates. These flap-intermediate structures thus open a new dimension into the molecular knowledge of the adaptability of drug-resistant protease mutants.
